EBOS Group stock last stood at NZD 20.40 on October 16, 30.85 percent below its high

EBOS Group's underlying operating earnings rose 5.0 percent to AUD 614.0 million in fiscal 2026, while the last NZX quote stood at NZD 20.40 on October 16, 2026 at 4:59 p.m. NZDT, up 0.25 percent versus the prior close. Kurums reported the earnings figures for the year ended June 30, 2026.

Operating earnings advance

The fiscal 2026 result shows revenue growth translating into a more measured earnings increase. Underlying net profit fell 3.1 percent to AUD 250.0 million, while statutory net profit was AUD 225.2 million, according to Kurums. The difference reflects higher depreciation and interest costs following the distribution-center investment program.

Price position and valuation

EBOS Group's NZD 20.40 last price was 30.85 percent below its NZD 29.50 52-week high and 10.57 percent above its NZD 18.45 52-week low. Trading volume reached 140,335 shares against an average of 206,536 shares on October 16, 2026.

The company had a market capitalization of NZD 4.3 billion, a P/E ratio of 15.50 and a dividend yield of 0.06 percent as of October 16, 2026. EBOS Group operates across healthcare distribution and animal care, with 5,364 full-time employees.

Annual meeting comes next

The next scheduled corporate date is EBOS Group's annual meeting on October 21, 2026. NZX published the company's 2026 notice and proxy form on September 17, 2026. The meeting gives shareholders the next formal checkpoint after the fiscal 2026 results.

Comparison with peers

EBOS Group (NZX, NZD): plus 0.25 percent, P/E 15.50, market capitalization NZD 4.3 billion
Sigma Healthcare (ASX, AUD): plus 1.42 percent, P/E 46.27, market capitalization AUD 32.8 billion
CSL (ASX, AUD): plus 2.84 percent, P/E minus 25.20, market capitalization AUD 92.2 billion

Trading position

EBOS Group's last quoted price was NZD 20.40 on the NZX on October 16, 2026 at 4:59 p.m. NZDT, up 0.25 percent versus the prior close of NZD 20.35.